Zobrazeno 1 - 10
of 239
pro vyhledávání: ''
Publikováno v:
Future Oncology. 17:2183-2192
Aim: To investigate the benefit of chemotherapy among early-stage breast cancer patients with 21-gene recurrence scores of 26–30. Methods: We identified 3754 patients in the Surveillance, Epidemiology, and End Results database. Results: 57.6% of th
Autor:
Sarah J. Nyante, Kathryn Earnhardt, Thad Benefield, Cherie M. Kuzmiak, Louise M. Henderson, Michael Pritchard
Publikováno v:
Cancer
BACKGROUND To understand how health care delays may affect breast cancer detection, the authors quantified changes in breast‐related preventive and diagnostic care during the coronavirus disease 2019 (COVID‐19) pandemic. METHODS Eligible women (N
Publikováno v:
Cancer Medicine, Vol 9, Iss 21, Pp 8043-8052 (2020)
Cancer Medicine
Cancer Medicine
Background An increasing number of patients undergo contralateral prophylactic mastectomy (CPM) for unilateral breast cancer. However, the benefit of CPM has not been quantified in the setting of contemporary breast cancer therapy. Methods We perform
Autor:
Michele L. Cote, Carly M Malburg, Julie J. Ruterbusch, Ann G. Schwartz, David M. Ledgerwood, Jennifer L. Beebe-Dimmer, Juliana Fucinari
Publikováno v:
Cancer Medicine, Vol 9, Iss 20, Pp 7763-7771 (2020)
Cancer Medicine
Cancer Medicine
Tobacco cessation among those recently diagnosed with cancer is important to improve their prognosis, yet, many cancer survivors continue to smoke. The epidemiology of tobacco use differs by race and ethnicity, and limited cessation research has been
Publikováno v:
Breast Cancer Research and Treatment. 180:481-490
Breast cancer is a major public health concern worldwide and shows significant heterogeneity between male and female. Knowing the global incidence landscape in both sexes is critical for the breast cancer prevention and the reduction in disease burde
Publikováno v:
Cancer Medicine
Cancer Medicine, Vol 9, Iss 5, Pp 1922-1936 (2020)
Cancer Medicine, Vol 9, Iss 5, Pp 1922-1936 (2020)
Background The associations between socioeconomic statuses and survival outcomes of breast cancer remain unclear. No model has included both histological and socioeconomic factors to predict the survival of breast cancer. This study was designed to d
Publikováno v:
Cancer Epidemiology. 61:104-110
Background This study examined the incidence of skeletal-related events (SRE) among patients with breast cancer (BC)- or prostate cancer (PC)-induced bone metastasis or multiple myeloma (MM) based on a population-based, 12-year healthcare database. M
Autor:
Gabrielle Emanuel, David Dodwell, Katherine E Henson, John Broggio, Jackie Charman, Kieran Horgan, Sarah C. Darby
Publikováno v:
Cancer Epidemiology
Highlights • Prescribing was as expected from clinical practice. • 90% received ET prescriptions during the second year after diagnosis. • Prescribing dropped more than five years after diagnosis. • The majority of younger women (under 55) re
Autor:
Arvind B Bambhroliya, Kim Anh Do, Tanmay R. Gandhi, Parijatham S. Thomas, Abenaa M. Brewster, Caleb A. Class
Publikováno v:
Cancer Causes Control
PURPOSE: Identifying demographic, clinical and geographical factors that contribute to disparities in the receipt of physician recommended chemotherapy in breast cancer patients. METHODS: The Texas Cancer Registry was used to identify women aged ≥
Autor:
Todd M Tuttle, Schelomo Marmor, Ariella M. Altman, Scott Kizy, Jane Yuet Ching Hui, James W. Begun, Bonnie Jerome-D'Emilia
Publikováno v:
Cancer Causes & Control. 30:129-136
The diagnosis of lobular carcinoma in situ (LCIS) is a strong risk factor for breast cancer. Endocrine therapy (ET) for LCIS has been shown to decrease breast cancer risk substantially. The purpose of this study was to evaluate the trends of ET use f